Research output per year
Research output per year
Personal profile
Expertises
Hematology, Oncology, Immunology, Cancer Immunetherapy
Main research areas
Cancer immunology
Current research
Targeting of neoantigens and immune regulatory proteins in patient with Philadelphia chromosome negative chronic myeloproliferative neoplasms by peptide vaccination
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Morten Orebo Holmström is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
Grauslund, J. H., Holmström, M. O., Martinenaite, E., Lisle, T. L., Glöckner, H. J., El Fassi, D., Klausen, U., Mortensen, R. E. J., Jørgensen, N., Kjær, L., Skov, V., Svane, I. M., Hasselbalch, H. C. & Andersen, M. H., 2023, In: Frontiers in Immunology. 14, p. 1117466 1117466.Research output: Contribution to journal › Journal article › Research › peer-review
-
Antibodies to calnexin and mutated calreticulin are common in human sera
Kyllesbech, C., Trier, N., Mughal, F., Hansen, P., Holmström, M., El Fassi, D., Hasselbalch, H., Skov, V., Kjær, L., Andersen, M., Ciplys, E., Slibinskas, R., Frederiksen, J., Højrup, P. & Houen, G., 28 Jan 2023, (E-pub ahead of print) In: Current research in translational medicine. 71, 2, p. 103380 103380.Research output: Contribution to journal › Journal article › Research › peer-review
-
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer
Mørk, S. K., Kongsted, P., Westergaard, M. C. W., Albieri, B., Granhøj, J. S., Donia, M., Martinenaite, E., Holmström, M. O., Madsen, K., Kverneland, A. H., Kjeldsen, J. W., Holmstroem, R. B., Lorentzen, C. L., Nørgaard, N., Andreasen, L. V., Wood, G. K., Christensen, D., Klausen, M. S., Hadrup, S. R., Thor Straten, P., & 2 others, 14 Mar 2023, In: Frontiers in Immunology. 14, p. 1122977 15 p., 1122977.Research output: Contribution to journal › Journal article › Research › peer-review
-
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy
Mortensen, R. E. J., Holmström, M. O., Lisle, T. L., Hasselby, J. P., Willemoe, G. L., Met, Ö., Marie Svane, I., Johansen, J., Nielsen, D. L., Chen, I. M. & Andersen, M. H., 22 Mar 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3, e006432.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, A. O., Enggaard, L., Hansen, M., Holmström, M. O., Met, Ö., Svane, I. M., Niemann, C. U., Pedersen, L. M. & Andersen, M. H., 2022, In: Frontiers in Oncology. 12, p. 1-13 13 p., 1023015.Research output: Contribution to journal › Journal article › Research › peer-review